This retrospective study evaluated the impact of a pre-emptive rituximab (RTX) strategy for EpsteinâBarr virus (EBV) reactivation on immune recovery and outcomes of 219 high-risk recipients undergoing allogeneic stem cell transplantation (allo-SCT)... Thank you for visiting nature.com. You are…
For almost 50 years, Fanconi anemia has been associated with leukemia. Not just among those who have the genetic disorder but among their family members, whose genes, they were told, made them highly susceptible to a variety of malignancies. But a…
October 28, 2026 / 6:07 PM CDT / CBS Texas A Texas teen hit with a medical emergency and a life-changing diagnosis is now giving back to other kids fighting for their lives. Heading to the driving range and picking up his golf club is…
A clinical trial will test zanubrutinib plus sonrotoclax as a fixed-duration, chemotherapy-free treatment for hairy cell leukemia, aiming for undetectable disease. Francesco Forconi: I am a Professor of Hematology at the University of Southampton, practicing at Southampton General Hospital. I…
Oct 27, 2026 | Cancer, Leukemia, Molecular Diagnostics | OGT has launched the SureSeq myPanel Myeloid Fusion MRD Panel, introducing the first dedicated fusion measurable residual disease (MRD) next-generation sequencing (NGS) panel for acute myeloid leukemia (AML) to the commercial market. In an initial…
At an AJMC Stakeholder Interchange in Houston, leukemia specialists from academic centers and community practices said menin inhibitors work best in combination, warned that differentiation syndrome can strike months into therapy, and described payer rules that delay access even at…
- Reaching the Pre-Specified 80th Event Triggers the Final Analysis of the Pivotal Phase 3 Trial - - Company to Report Topline Primary Endpoint Results this Quarter - About Phase 3 REGAL Trial The Phase 3 REGAL trial (NCT04229979) is a randomized registrational clinical trial evaluating GPS as a…
Newswise — MIAMI, FLORIDA (EMBARGOED UNTIL DEC. 6, 2025, AT 8:30AM) – For years, the search for a stem cell donor has felt like a quest for a rare key—one that fits a lock with eight intricate tumblers, each representing a genetic marker. For…
As a first treatment for someone with a rare white blood cell cancer (MTCL), giving someone stem cells from another person (alloSCT) rather than their own stem cells (autoSCT) may make little or no difference to their chance of treatment…
Mary Jo Lechowicz, MD, discussed how pre-transplant depth of response informs the choice between autologous and allogeneic HSCT in T-cell lymphoma. In an interview with CancerNetwork® at the 2026... In an interview with CancerNetwork® at the 2026 Society of Hematologic Oncology (SOHO)…
Leukaemia in adults and children - AML, ALL, CLL and CML: treatment and research.
An article joins this feed when it matches these terms. Each one is also a search of its own.